Skip to content

Usefulness and safety of colonic transit time test

Usefulness and safety of colonic transit time test - Usefulness and safety of colonic transit time test

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047511
Enrollment
100
Registered
2022-04-26
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic constipation

Interventions

Five days after taking a capsule of 24 radiopaque markers, a plain abdominal X-ray examination is performed.

Sponsors

Jichi Medical University Department of surgery, Division of Gastroenterological General and Transplant Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients with chronic constipation who visit our institution, complaining of infrequent bowel motion, abdominal pain, abdominal bloating, evacuation difficulty and incomplete defecation.

Exclusion criteria

Exclusion criteria: 1, Pregnancy or possibility of pregnancy 2, Allergy to barium sulfate

Design outcomes

Primary

MeasureTime frame
1, Subjective evaluation by researchers of the usefulness of colonic transit time test based on the results of colonic transit time test 2, Subjective evaluation by patients of the usefulness of colonic transit time test based on the results of colonic transit time test

Secondary

MeasureTime frame
1, Number and location of radiopaque markers remaining in the colorectum on the 5th day after their oral administration 2, Severity of slow colonic transit, depending on the number of radiopaque markers remaining in the large bowel on the 5th day after their oral administration 3, Number of days until radiopaque markers are completely evacuated 4, Comparison of subjective evaluations between researchers and patients 5, Interobserver agreement between researchers regarding their subjective evaluation 6, Incidence of adverse events

Countries

Japan

Contacts

Public ContactYuko Homma

Jichi Medical University Department of surgery, Division of Gastroenterological General and Transplant Surgery

y.homma@jichi.ac.jp0285587371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026